NDAOPHTHALMICSUSPENSION/DROPS
Approved
Apr 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Mechanism of Action
CLINICAL PHARMACOLOGY Betaxolol hydrochloride, a cardioselective (beta 1 ) adrenoceptor antagonist, does not have significant membrane-stabilizing (local anesthetic) activity and is devoid of intrinsic sympathomimetic action. Orally administered beta-adrenergic blocking agents reduce cardiac output…